BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36158667)

  • 1. Systemic treatment for primary malignant sarcomas arising in craniofacial bones.
    Bielack SS
    Front Oncol; 2022; 12():966073. PubMed ID: 36158667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
    Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
    Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Primary Malignant Bone Sarcomas.
    Palmerini E; Righi A; Staals EL
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review.
    König M; Osnes T; Bruland Ø; Sundby Hall K; Bratland Å; Meling TR
    Front Oncol; 2020; 10():1402. PubMed ID: 32850452
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of imaging of surface sarcomas of bone.
    Harper K; Sathiadoss P; Saifuddin A; Sheikh A
    Skeletal Radiol; 2021 Jan; 50(1):9-28. PubMed ID: 32681279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates in common pediatric and adult bone sarcomas.
    Heymann MF; Lezot F; Heymann D
    Bone; 2020 Oct; 139():115523. PubMed ID: 32622877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
    Fadare O
    Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas.
    Saifuddin A; Sharif B; Oliveira I; Kalus S; Barnett J; Pressney I
    Skeletal Radiol; 2020 Jun; 49(6):945-954. PubMed ID: 31919587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ewing Sarcoma of the Craniofacial Bones: A Qualitative Systematic Review.
    Rehman R; Osto M; Parry N; Awada N; Agemy J; Arianpour K; Folbe AJ
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):608-614. PubMed ID: 34255595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
    Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing sarcoma and Ewing-like tumors.
    Sbaraglia M; Righi A; Gambarotti M; Dei Tos AP
    Virchows Arch; 2020 Jan; 476(1):109-119. PubMed ID: 31802230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
    Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
    Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
    Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
    Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile Spine Osseous Sarcoma: Descriptive Epidemiological Analysis Based on a National Population-Based Study.
    Ebrahimpour A; Chehrassan M; Sadighi M; Azizmohammad Looha M; Karimi A; Raeisi A; Zali A; Akbari ME
    Arch Iran Med; 2021 Aug; 24(8):629-635. PubMed ID: 34488331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.